Know Labs, Inc. (NYSE American: KNW), a pioneer in non-invasive medical diagnostic technology, has unveiled its latest innovation, the KnowU™. This wearable continuous glucose monitor (CGM) marks a significant milestone following the announcement of its initial prototype in June 2023,…
Today, Inogen, Inc. (Nasdaq: INGN), a leading medical technology company providing innovative respiratory solutions for homecare, unveiled its financial performance for the fourth quarter and full-year ending December 31, 2023. Inogen, Inc. (Nasdaq: INGN), a leading provider of innovative respiratory…
REVEAL GENOMICS, S.L., a pioneering biotechnology start-up based in Barcelona that is poised to transform precision oncology with its biomarker innovations, has announced the start of the DEFINITIVE study, led by FRCB-IDIBAPS, representing the first prospective trial for HER2DX®. The…
Today, Exact Sciences Corp., renowned for its cancer screening and diagnostic solutions, unveiled the introduction of the Riskguard™ hereditary cancer test across the United States. This innovative test furnishes personalized patient reports detailing gene-specific and familial risks for 10 prevalent…
Swiss Advanced Vision (SAV-IOL SA), a renowned company specializing in advanced vision solutions, has recently introduced new features to its Toric Calculator, aiming to enhance the overall calculation process for ophthalmologists. This innovative update marks a significant milestone in cataract…
Cleerly, a pioneer in heart disease diagnosis, has announced that its FDA-cleared Cleerly ISCHEMIA software, applied to non-invasive coronary CT angiograms (CCTA), can now be billed using the new Category I CPT® code 75580. This service, defined by the AMA…
Amidst unprecedented challenges across the health care industry and within its system, Steward Health Care announced today a six-point action plan that will enable the organization to emerge as a sustainable business and move into its next operational phase. Steward…
The “Global IV Catheters Market – Focused Insights 2024-2029” report is now available on ResearchAndMarkets.com. The global IV catheters market reached USD 4.93 billion in 2023 and is anticipated to hit $6.64 billion by 2029, with a CAGR of 5.04%.…
Today, Oticon, Inc. introduces Oticon Intent™, the world’s pioneering hearing aid featuring user-intent sensors designed to comprehend and adjust to individuals’ preferences in challenging listening environments. With its innovative technology, Oticon Intent aims to enhance the engagement of people with…
Radiology Partners (RP), the top radiology practice in the U.S. and its affiliated practices, has successfully concluded a series of financial transactions. These include a $720 million growth equity investment, an exchange offer for existing notes, and an amendment to…
Abridge, a pioneer in generative AI for clinical documentation, has secured an additional $150 million investment, building on the success of its product adopted by health systems nationwide. This funding round follows their $30 million Series B just four months…
Orca Bio, a biotech firm advancing precise cell therapies for cancer, autoimmune disorders, and genetic blood conditions, has unveiled promising results for its lead investigational therapy, Orca-T, at the 2024 Tandem Meetings hosted by ASTCT and CIBMTR. In the first…